Medical experts discuss strategies to connect with patients to alleviate concerns potentially associated with converting heart failure therapies.
This is a video synopsis/summary of a panel discussion involving Robert Groves, MD; Eugene E. Wright Jr, MD; Nancy Albert, PhD; Nihar Desai, MD, MPH; and Kelly Marie Axsom, MD. The panel discusses strategies for converting stable heart failure patients from angiotensin-converting enzyme (ACE) inhibitors to angiotensin receptor-neprilysin inhibitor (ARNI) therapy. Albert emphasizes shared decision-making, explaining the benefits of switching, trying the new therapy, and reassessing how the patient feels. Once aware of improvements, patients are motivated to continue. Albert notes explaining therapeutic mechanisms helps, as ARNIs can actually reduce heart size versus just preventing enlargement with ACE inhibitors. Another of the 4 pillars of heart failure (HF) therapy, sodium-glucose cotransporter-2 (SGLT2) inhibitors, emerged unexpectedly from diabetes trials, reducing cardiovascular deaths across ejection fraction ranges. The ability to use SGLT2 inhibitors across HF spectrums makes adoption easier. For primary prevention, high-risk diabetes patients should receive SGLT2 inhibitors. In summary, SGLT2 inhibitors have rapidly become a core HF therapy thanks to unexpected cardiovascular benefits seen in diabetes trials. Their broad applicability creates substantial opportunities to improve outcomes across HF populations.
Video synopsis is AI-generated and reviewed by AJMC editorial staff.
Enhancing Outpatient Hemophilia Care May Improve Health Outcomes and Costs
May 18th 2024Prospective data from patients attending a rural practice in West Virginia between 2016 and 2023 show that a quality improvement program that followed guideline recommendations and was tailored to specific patient needs reduced preventable bleeds and lowered costs.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Enhancing Outpatient Hemophilia Care May Improve Health Outcomes and Costs
May 18th 2024Prospective data from patients attending a rural practice in West Virginia between 2016 and 2023 show that a quality improvement program that followed guideline recommendations and was tailored to specific patient needs reduced preventable bleeds and lowered costs.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
2 Commerce Drive
Cranbury, NJ 08512